Tsutomu Yoshihara

Yokohama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Bifidobacterium bifidum G9-1 and Quality of Life in Chronic Constipation: A Multicenter, Double-Blind, Randomized Controlled Trial.

Bifidobacterium bifidum G9-1 and Quality of Life in Chronic Constipation: A Multicenter, Double-Blind, Randomized Controlled Trial.

Journal: Digestion

Published: August 24, 2025

A Handheld Ultrasound Device Can Predict Constipation with Rectal Fecal Retention in a Palliative Care Setting.

A Handheld Ultrasound Device Can Predict Constipation with Rectal Fecal Retention in a Palliative Care Setting.

Journal: Diagnostics (Basel, Switzerland)

Published: May 27, 2024

Efficacy and safety of linaclotide in treatment-resistant chronic constipation: A multicenter, open-label study.

Efficacy and safety of linaclotide in treatment-resistant chronic constipation: A multicenter, open-label study.

Journal: Neurogastroenterology and motility

Published: April 02, 2024

Diagnostic Ability of Ultrasonography Compared with Computed Tomography for Assessing Rectal Feces.

Diagnostic Ability of Ultrasonography Compared with Computed Tomography for Assessing Rectal Feces.

Journal: Journal of the anus, rectum and colon

Published: November 02, 2023

Strain-level detection of Fusobacterium nucleatum in colorectal cancer specimens by targeting the CRISPR-Cas region.

Strain-level detection of Fusobacterium nucleatum in colorectal cancer specimens by targeting the CRISPR-Cas region.

Journal: Microbiology spectrum

Published: October 11, 2023

Efficacy and safety of rifaximin in patients with chronic intestinal pseudo-obstruction: a randomized, double-blind, placebo-controlled, phase II-a exploratory trial.

Efficacy and safety of rifaximin in patients with chronic intestinal pseudo-obstruction: a randomized, double-blind, placebo-controlled, phase II-a exploratory trial.

Journal: Bioscience of microbiota, food and health

Published: September 24, 2023

Prior appendectomy and cerebral infarction as potential risk factors for recurrent ischemic colitis: A retrospective observational study.

Prior appendectomy and cerebral infarction as potential risk factors for recurrent ischemic colitis: A retrospective observational study.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: September 21, 2022

The Prevalence and Characteristics of Symptomatic Uncomplicated Diverticular Disease Among Asian Patients With Unexplained Abdominal Symptoms.

The Prevalence and Characteristics of Symptomatic Uncomplicated Diverticular Disease Among Asian Patients With Unexplained Abdominal Symptoms.

Journal: Journal of neurogastroenterology and motility

Published: September 20, 2022

Natural History of Chronic Intestinal Pseudo-obstruction and Need for Palliative Care.

Natural History of Chronic Intestinal Pseudo-obstruction and Need for Palliative Care.

Journal: Journal of neurogastroenterology and motility

Published: September 05, 2022

Clinicopathological features of endoscopically treated early gastric cancer with lymphovascular infiltration.

Clinicopathological features of endoscopically treated early gastric cancer with lymphovascular infiltration.

Journal: Journal of cancer research and clinical oncology

Published: September 02, 2022

Exploratory, multicenter, open-label study to evaluate the effects of linaclotide in patients with chronic constipation with an insufficient response to magnesium oxide: A study protocol.

Exploratory, multicenter, open-label study to evaluate the effects of linaclotide in patients with chronic constipation with an insufficient response to magnesium oxide: A study protocol.

Journal: Contemporary clinical trials communications

Published: August 08, 2022

Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation.

Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation.

Journal: BMJ open

Published: May 31, 2022

Showing 1-12 of 32

Last Updated: 09/26/2026